Description:LY2979165, with the CAS number 1311385-32-6, is a chemical compound that has been investigated primarily for its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective inhibitor of certain enzymes, particularly those involved in the modulation of neurotransmitter systems. This compound has garnered attention in the field of neuroscience and psychiatry, particularly for its potential role in treating conditions such as depression and anxiety disorders. The structure of LY2979165 features specific functional groups that contribute to its biological activity and selectivity. In preclinical studies, it has shown promise in modulating synaptic transmission and influencing neuroplasticity. As with many investigational compounds, ongoing research is essential to fully elucidate its pharmacokinetics, safety profile, and therapeutic efficacy. Overall, LY2979165 represents a significant area of interest in drug development, particularly in the context of mental health treatments.
(1R,2S,4R,5R,6R)-4-((4H-1,2,4-Triazol-3-yl)thio)-2-((S)-2-aminopropanamido)bicyclo[3.1.0]hexane-2,6-dicarboxylic acid is a bicyclic compound that is an allosteric modulator of metabotropic glutamate receptors. …
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![(1R,2S,4R,5R,6R)-4-((4H-1,2,4-Triazol-3-yl)thio)-2-((S)-2-aminopropanamido)bicyclo[3.1.0]hexane-2,…](https://static.cymitquimica.com/products/3D/thumb/LCC38532.jpg)
